Morgan Stanley Fsd Pharma Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.96 - $1.63 $960 - $1,630
-1,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.45 - $1.84 $1,450 - $1,840
1,000 New
1,000 $2,000

About FSD Pharma Inc.

HUGE Quotes by TradingView
  • Ticker HUGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 38,218,100
  • Market Cap $146M
  • Description
  • FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...
More about HUGE
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email